Precision Compounding Listed by dragonforce Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

Inside the incident

The only confirmed public information is the December 05, 2025 listing on dragonforce’s site. The group claims internal files were exfiltrated. No official statement from Precision Compounding has disclosed the number of records involved, the exact date of the intrusion, or whether any data was later published. Timing, scale, and method of access are therefore undisclosed.

Inside dragonforce

Dragonforce is a ransomware operation that targets organizations across multiple sectors. Its typical pattern involves encrypting systems, copying data, and posting victim names on a leak site when ransom demands are not met. The group’s listings function as public claims rather than independently verified incidents. Prior activity attributed to dragonforce has included healthcare and manufacturing entities, though each case requires separate confirmation.

Precision Compounding and its sector

Precision Compounding prepares individualized medications for patients in collaboration with prescribers. Its work covers areas such as dermatology, hormone therapies, veterinary formulations, and nutritional compounds. Organizations of this type routinely collect and store patient identifiers, prescription details, medical histories, and insurance information to fulfill orders and maintain regulatory compliance.

What was likely exposed

The listing refers only to “internal files.” The precise contents have not been disclosed. Compounding pharmacies commonly retain records that include names, dates of birth, addresses, medication formulations, and clinical notes. Until the organization or investigators publish an inventory, the exact data types remain unconfirmed.

What's at stake

Individuals whose information appears in pharmacy records face the possibility of identity misuse or targeted fraud if those files circulate. For the organization, exposure of formulation data or patient correspondence can affect trust and regulatory standing. Both outcomes depend on what the files actually contain and whether they are released or sold.

Were you affected?

Begin by contacting Precision Compounding directly for any official notification. Review statements from your healthcare providers and insurers for unusual activity. Place fraud alerts with credit bureaus if personal identifiers may be involved. A free exposure scan of your email address against known breach repositories can show whether your information has already appeared in public data sets.

• Request confirmation from the pharmacy about any notices sent to patients.
• Monitor bank and insurance accounts for unauthorized transactions.
• Consider a credit freeze if sensitive identifiers were stored.
• Retain records of any correspondence with the organization.

AICompiled with AI assistance from public sources and published under our editorial standards.